The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

On November 5, 2008, Bayer (the maker of Trasylol) removed the drug from the shelves due to safety reasons. Trasylol is a clotting drug that is used during heart surgeries to prevent bleeding, but the FDA says that the clotting drug poses an increased death risk.

“Studies have found that Trasylol can increase the risk of kidney damage compared with other drugs,” Dr. Gerald Dal Pan, the FDA’s director of the office of Surveillance and Epidemiology, said during a news conference.

Side effects associated with Trasylol include an increased risk of:

Kidney Failure (Renal Failure)

Heart attack


Blood Clot (Thrombosis


Patients who experienced any of these side effects should immediately contact their medical providers to find out of Trasylol was used during their procedure.

If Trasylol has affected you or someone you know, contact the office of Reich and Binstock for an evaluation of your case.

Comments are closed.

Of Interest